Literature DB >> 24533870

Validation of quantitative analysis of multiparametric prostate MR images for prostate cancer detection and aggressiveness assessment: a cross-imager study.

Yahui Peng1, Yulei Jiang, Tatjana Antic, Maryellen L Giger, Scott E Eggener, Aytekin Oto.   

Abstract

PURPOSE: To validate three previously identified quantitative image features across multiparametric magnetic resonance (MR) images acquired with imagers made by two different manufacturers to differentiate prostate cancer (PC) from normal prostatic tissue and to assess cancer aggressiveness.
MATERIALS AND METHODS: This study was HIPAA-compliant and approved by the institutional review board. Preoperative 1.5-T multiparametric endorectal MR images of 119 PC patients (dataset A, 71 patients; dataset B, 48 patients) were analyzed, and 265 PC and normal peripheral zone regions of interests (ROIs) were identified through histologic and MR consensus review. The 10th percentile average apparent diffusion coefficient (ADC) value, average ADC value, and skewness of T2-weighted signal-intensity histogram were evaluated with area under the receiver operating characteristic curve (AUC). The image features were combined with a linear discriminant analysis classifier and evaluated both on the image dataset of each type of imager alone (leave-one-patient-out evaluation) and across the datasets (training on one dataset, testing on the other). Spearman correlation coefficient was calculated between the image features and ROI-specific Gleason scores.
RESULTS: AUC values of the image features combined were 0.95 ± 0.02 (standard error) and 0.88 ± 0.03 on dataset B and dataset A alone, respectively, and 0.96 ± 0.02 and 0.89 ± 0.03 when training on dataset A and testing on dataset B and vice versa, respectively. Spearman correlation coefficients between Gleason scores and the ADC features were between -0.27 and -0.34.
CONCLUSION: Consistently across images from datasets A and B, the 10th percentile ADC value, average ADC value, and T2-weighted skewness can distinguish PC from normal-tissue ROIs, and ADC features correlate moderately with ROI-specific Gleason scores.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24533870     DOI: 10.1148/radiol.14131320

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  Restriction spectrum imaging improves MRI-based prostate cancer detection.

Authors:  Kevin C McCammack; Natalie M Schenker-Ahmed; Nathan S White; Shaun R Best; Robert M Marks; Jared Heimbigner; Christopher J Kane; J Kellogg Parsons; Joshua M Kuperman; Hauke Bartsch; Rahul S Desikan; Rebecca A Rakow-Penner; Michael A Liss; Daniel J A Margolis; Steven S Raman; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  Abdom Radiol (NY)       Date:  2016-05

Review 2.  Multiparametric MRI for prostate cancer diagnosis: current status and future directions.

Authors:  Armando Stabile; Francesco Giganti; Andrew B Rosenkrantz; Samir S Taneja; Geert Villeirs; Inderbir S Gill; Clare Allen; Mark Emberton; Caroline M Moore; Veeru Kasivisvanathan
Journal:  Nat Rev Urol       Date:  2019-07-17       Impact factor: 14.432

3.  In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.

Authors:  K C McCammack; C J Kane; J K Parsons; N S White; N M Schenker-Ahmed; J M Kuperman; H Bartsch; R S Desikan; R A Rakow-Penner; D Adams; M A Liss; R F Mattrey; W G Bradley; D J A Margolis; S S Raman; A Shabaik; A M Dale; D S Karow
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-12       Impact factor: 5.554

4.  Diagnostic performance of 68Ga-PSMA PET/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections.

Authors:  Jie Gao; Chengwei Zhang; Qing Zhang; Yao Fu; Xiaozhi Zhao; Mengxia Chen; Bing Zhang; Danyan Li; Jiong Shi; Feng Wang; Hongqian Guo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-25       Impact factor: 9.236

5.  Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.

Authors:  Yuji Iyama; Takeshi Nakaura; Kazuhiro Katahira; Ayumi Iyama; Yasunori Nagayama; Seitaro Oda; Daisuke Utsunomiya; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

6.  Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.

Authors:  Shoshana B Ginsburg; Ahmad Algohary; Shivani Pahwa; Vikas Gulani; Lee Ponsky; Hannu J Aronen; Peter J Boström; Maret Böhm; Anne-Maree Haynes; Phillip Brenner; Warick Delprado; James Thompson; Marley Pulbrock; Pekka Taimen; Robert Villani; Phillip Stricker; Ardeshir R Rastinehad; Ivan Jambor; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2016-12-19       Impact factor: 4.813

7.  The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.

Authors:  Stephanie Nougaret; Nicola Robertson; Jennifer Golia Pernicka; Nicolas Molinari; Andreas M Hötker; Behfar Ehdaie; Evis Sala; Hedvig Hricak; Hebert Alberto Vargas
Journal:  Abdom Radiol (NY)       Date:  2017-07

Review 8.  Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.

Authors:  Ryan L Brunsing; Natalie M Schenker-Ahmed; Nathan S White; J Kellogg Parsons; Christopher Kane; Joshua Kuperman; Hauke Bartsch; Andrew Karim Kader; Rebecca Rakow-Penner; Tyler M Seibert; Daniel Margolis; Steven S Raman; Carrie R McDonald; Nikdokht Farid; Santosh Kesari; Donna Hansel; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

Review 9.  Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.

Authors:  Lizhi Liu; Zhiqiang Tian; Zhenfeng Zhang; Baowei Fei
Journal:  Acad Radiol       Date:  2016-04-25       Impact factor: 3.173

10.  Magnetic barcode imaging for contrast agents.

Authors:  Andy H Hung; Laura M Lilley; Fengqin Hu; Victoria S R Harrison; Thomas J Meade
Journal:  Magn Reson Med       Date:  2016-04-08       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.